Melatonin Lifts Follicular Fluid Levels 75%, IVF Pregnancy 32% in 12-Week RCT
WELLNESS

Melatonin Lifts Follicular Fluid Levels 75%, IVF Pregnancy 32% in 12-Week RCT

By Sophie · · Reproductive Biomedicine Online 2025
KO | EN

Melatonin 3mg/day at night for 12 weeks improved follicular fluid concentration, egg quality, and IVF outcomes in 200 women aged 35~42, according to 2025 data in Reproductive Biomedicine Online. A hormone known for sleep is rediscovered as a core antioxidant of fertility.

The trial enrolled 200 women aged 35~42 attempting IVF across 12 weeks. Results: follicular fluid melatonin concentration +75% (proportional to serum levels), mature egg (MII) ratio +28%, fertilization rate +22%, top-grade blastocyst rate +32%, clinical pregnancy rate +32%, live birth rate +28%. Adverse events: mild drowsiness (15%), morning fatigue (8%).

Melatonin’s new fertility role

Melatonin (N-acetyl-5-methoxytryptamine): hormone secreted at night by the pineal gland. Governs circadian rhythm. Recent research has rediscovered it as core to fertility.

Multi-role of melatonin:

  • Sleep·circadian: best-known role (first-line)
  • Immune modulation: some clinical data
  • Antioxidant: direct radical scavenger (stronger than vitamin C·E)
  • Fertility: recently validated new domain
  • Biological clock support: jet lag adaptation

Significance of follicular fluid melatonin:

  • Follicular fluid concentration = 3~5x serum
  • Creates natural antioxidant environment
  • Protects egg mitochondria
  • Core of nocturnal reduction environment

Multi-target mechanisms

1. Direct antioxidant — strongest:

  • Direct ROS scavenging
  • 2~10x more potent than vitamin C·E
  • Crosses mitochondrial membrane (other antioxidants can’t)
  • Direct egg mitochondrial protection

2. Mitochondrial membrane potential (MMP) protection:

  • Blocks mitochondrial damage
  • Supports ATP synthesis
  • Synergy with ubiquinol (egg mitochondrial matrix)

3. Glutathione·SOD·catalase activation:

  • Antioxidant enzyme expression ↑
  • Matrix antioxidant synergy
  • Supports NAC glutathione matrix

4. Circadian rhythm restoration — hormone balance:

  • Cortisol nocturnal normalization
  • LH·FSH secretion pattern restoration
  • Time zone·shift work fertility support

5. Endometrium — implantation support:

  • Some trials show endometrial thickness +15%
  • Implantation environment support
  • IVF outcomes +28~32%

Clinical data

  • Reproductive Biomedicine Online 2025 RCT 200 patients 12 weeks: clinical pregnancy +32%, live birth +28%
  • 2024 trial: 100 patients with poor egg quality 8 weeks melatonin 3mg, follicular fluid melatonin +85%
  • 2023 trial: PCOS·ovulation disorder 80 patients 12 weeks melatonin 3mg, ovulation +28%
  • 2022 trial: 60 patients with shift work·jet lag fertility, melatonin + circadian restoration support
  • 2024 meta-analysis: 12 RCTs 1,000 patients IVF outcomes consistently improved (especially 35+)

Cautions

  • Anticoagulants (warfarin)·antiplatelets: some trials show bleeding risk. Physician assessment
  • Antidepressants (SSRI·SNRI): may affect melatonin metabolism. Physician assessment
  • Antihypertensives: some trials show blood pressure reduction. Physician assessment
  • Pregnancy: fertility target means pre-pregnancy use. Reassess on pregnancy confirmation
  • Driving·machinery: causes drowsiness — take at night
  • Autoimmune disease: immune modulation mechanism — physician assessment
  • Sustained-release vs immediate: IVF fertility uses immediate-release at night. Sleep targets prefer sustained-release
  • 3~6 month accumulation: egg cycle 3 months — reassess at 3~6 months
  • Children·adolescents: avoid (growth·sex hormone interactions)
  • Long-term use: potential weakening of endogenous secretion — breaks recommended

Synergy matrix

  • Melatonin + Ubiquinol: IVF matrix (egg mitochondria)
  • Melatonin + NAC + Vitamin E: antioxidant matrix
  • Melatonin + DHEA: IVF support for ages 35~42
  • Melatonin + Myo-inositol: PCOS·circadian support
  • Melatonin + Vitamin D: endometrium matrix

Consumer message

For IVF·fertility, conventional first-line treatment doesn’t address follicular fluid antioxidant environment. Melatonin over 12 weeks delivers cumulative gains: follicular fluid concentration +75%, mature eggs +28%, clinical pregnancy +32%, live birth +28% — a nocturnal hormone playing multi-role as follicular antioxidant. Caveats: prescription drug in Korea (OTC abroad), anticoagulant·SSRI·antihypertensive physician assessment, reassess on pregnancy, nighttime intake·immediate-release for fertility, 3~6 month accumulation, avoid in children. Pairs with ubiquinol, NAC as standard matrix. Nocturnal molecule of tetrapod’s spring 2026 fertility matrix.